Значения термина reduce ejection на английском

Background: Impaired contractility is a feature of heart failure with reduced ejection fraction.

Methods and results: This randomized clinical trial involved 180 HF outpatients with reduced ejection fraction.

These effects reduce those processes that can lead to heart failure with reduced ejection fraction.

Eccentric hypertrophy develops in volume overload conditions and leads wall thinning, chamber dilation, and reduced ejection fraction.

Background: Congestive heart failure with reduced ejection fraction is a common clinical condition with a serious prognosis.

Roughly half of them suffer from a subtype known as reduced ejection fraction that Farxiga was approved for.

In patients hospitalized with heart failure, HFpEF is now as common as heart failure with reduced ejection fraction.

However, the subgroup of patients with reduced ejection fraction and AF have been speculated to derive clinical benefit from digoxin.

Design, setting, and patients: Multicenter, randomized controlled trial of 2331 medically stable outpatients with heart failure and reduced ejection fraction.

Conclusions: Regardless of pre-treatment heart rate, beta-blockers reduce mortality in patients with heart failure with reduced ejection fraction in sinus rhythm.

Hypothesis: We aimed to compare CA to medical therapy in AF patients with HF with reduced ejection fraction (HFrEF).

Background: The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known.

Background: SCD still accounts for a significant proportion of overall mortality in heart failure with reduced ejection fraction (HFrEF).

We now have many successful treatments for heart failure with reduced ejection fraction, while specific treatment options for HFpEF patients remain elusive.

In this review, we summarize current knowledge of right ventricular mechanics in heart failure with reduced ejection fraction and preserved ejection fraction.

Objective: We assessed the hypothesis that ubiquinol improves peripheral endothelial function in patients with heart failure with reduced ejection fraction (HFrEF).